Trial intelligence / Profile preview

Omega 3 Fatty Acid Supplements in Heavy Smokers

NCT03936621Phase 2Unknown

Sponsor
BC Cancer
Start
Jun 2019
Primary completion
Jun 2021
Modality
Small Molecules
01

Overview

A Phase 2 trial of omega-3 long-chain polyunsaturated fatty acids in lung cancer, sponsored by BC Cancer. Status: unknown.

02

Drugs

omega-3 long-chain polyunsaturated fatty acids
03

Conditions

lung cancer

Beyond the preview

Go deeper on NCT03936621.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03936621.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call